Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
varian.com

See what CB Insights has to offer

Investments

15

Portfolio Exits

4

Partners & Customers

10

Service Providers

1

About Varian Medical Systems

Varian Medical Systems (NYSE: VAR) manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications, and X-ray imaging products for cargo screening and industrial inspection.

Varian Medical Systems Headquarter Location

3100 Hansen Way

Palo Alto, California, 94304,

United States

650-493-4000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Varian Medical Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Varian Medical Systems in 6 Expert Collections, including Health IT .

H

Health IT

2,848 items

C

Conference Exhibitors

5,302 items

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

D

Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

M

Medical Devices

3,483 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

H

Health Monitoring & Diagnostics

313 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging

Research containing Varian Medical Systems

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Varian Medical Systems in 1 CB Insights research brief, most recently on Mar 21, 2022.

Latest Varian Medical Systems News

Oncological Treatment Centers to Boost the use of Radiotherapy Devices – Fact.MR Exclusive Survey

May 17, 2022

Oncological Treatment Centers to Boost the use of Radiotherapy Devices – Fact.MR Exclusive Survey 250 Pages Radiotherapy Devices Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider According to Fact MR’s recent market research,  sales to Radiotherapy Devices  to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges. Focus on improving overall patient care will remain a chief growth driver. Besides this, Radiotherapy Devices market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare. To remain ‘ahead’ of your competitors, request for a sample –   https://www.factmr.com/connectus/sample?flag=S&rep_id=77 Market Snapshot The global radiotherapy devices market reached a valuation of around US$ 5 Bn in 2020, which amounts to close to 4% share of the overall oncology devices market. Sales of radiotherapy equipment are slated to accelerate at a CAGR of 7% to top US$ 10 Bn by 2031. Demand for linear accelerator devices, which holds the highest market share, is set to increase at a CAGR of 6% across the assessment period of 2021 to 2031. Radiotherapy Devices Market Size in 2020 US$ 5 Bn 50%   The report offers actionable and valuable market insights of Radiotherapy Devices. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Radiotherapy Devices Market across various industries and regions. This newly published and insightful report sheds light on Market Insights of Radiotherapy Devices, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Radiotherapy Devices Market. Key Market Segments in Radiotherapy Devices Industry Research ·                   Product Type Advanced Radiotherapy Systems for Cancer Treatment External Beam Radiotherapy for Prostate Cancer External Beam Radiotherapy for Breast Cancer External Beam Radiotherapy for Lung Cancer External Beam Radiotherapy for Head and Neck Cancer External Beam Radiotherapy for Colorectal Cancer Internal Beam Radiotherapy for Prostate Cancer Internal Beam Radiotherapy for Gynecological Cancer Internal Beam Radiotherapy for Breast Cancer Internal Beam Radiotherapy for Cervical Cancer Internal Beam Radiotherapy for Penile Cancer ·                   End User Use of Radiotherapy Devices in Independent Radiotherapy Centers Full Access of this Exclusive Report is Available at-   https://www.factmr.com/checkout/77 Competitive Landscape The radiation therapy devices market is highly competitive and consists of a few leading manufacturers of radiotherapy devices. In June 2020, Accuray announced the Cyberknife S7 system, which enables improved accuracy and real-time artificial intelligence powered motion tracking. This radiotherapy device is used to deliver treatments such as stereotactic radiosurgery, and stereotactic body radiation therapy. Cyberknife S7 system is a robotic, non-invasive radiation therapy device that can be used to treat malignant and benign tumours as well as neurologic problems across the body. Key Projections on the Global Radiotherapy Devices Market: In 2017, global sales of linear accelerator devices is expected to procure nearly half of global radiotherapy devices market value. The sales of linear accelerators for radiotherapy is expected to gain steadfast traction, procuring an annual growth of more than US$ 280 Mn from 2017 to 2022. With soaring incidence of cancers across European countries, the healthcare infrastructure in this region is expected to remain lucrative for adoption of effective cancer therapies such as radiotherapy. The demand for radiotherapy devices is expected to gain traction in Europe owing to its advantage over other cancer therapeutic devices in terms of controlling the growth of the malignant tumors. Moreover, cancer patients are likely to remain more inclined towards radiotherapy devices that limit the hospital stay duration. According to the report, Europe will remain the largest market for radiotherapy devices throughout the forecast period. In North America, changing lifestyles of consumers and penetration of urban cultures is fuelling the incidence of pancreatic cancer. Radiotherapy devices are expected to remain of great use in treatment of pancreatic cancer and borderline resectable cancer. The radiotherapy devices market in North America is expected to witness robust gains throughout the forecast period. Manufacturers of radiotherapy devices are expected to view the Asia-Pacific excluding Japan (APEJ) region as lucrative for setting up production units. Favorable industrial regulations, low wages and high resource availability is expected to drive the growth of radiotherapy devices market in the APEJ region. The report predicts that the APEJ radiotherapy devices market is expected to grow at the fastest pace, reflecting a stellar CAGR of 11.5% through 2022. Towards the end of 2022, hospitals will emerge to be the largest end-users of radiotherapy devices. The demand for radiotherapy devices in oncological treatment centers is also anticipated to gain traction, procuring over one-fourth share on global market values throughout the forecast period. The report has profiled leading manufacturers of radiotherapy devices which are expected to remain active in the expansion of global market, and these include Varian Medical Systems, RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, Elekta AB, Accuray, Inc., IsoRay, Inc., GE Healthcare, Vision RT Ltd., C.R. Bard, Inc., Koninklijke Philips N.V., Siemens AG, IBA Ion Beam Applications SA, Eckert & Ziegler Bebig, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co., Ltd. and AngioDynamics, Inc. Read More Trending Reports of Fact.MR- Report Benefits & Key Questions Answered Radiotherapy Devices Category and segment level analysis:Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level. Radiotherapy Devices Historical volume analysis: The report provides a comparison of Radiotherapy Devices’s historical sales and projected sales performance for 2021-2031. Radiotherapy Devices Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Radiotherapy Devices market. It carefully gauges the impact of changing healthcare needs of key demographics globally Radiotherapy Devices Consumption by demographics: The report investigates consumer behavior affecting Radiotherapy Devices demand outlook for the assessment period. Effect of their keenness for digital trends on Radiotherapy Devices market is carefully analyzed Post COVID consumer spending on Radiotherapy Devices: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Radiotherapy Devices market growth. More Valuable Insights on Radiotherapy Devices Market Fact.MR, in its new report, offers an unbiased Market Analysis of Radiotherapy Devices, Sales and Demand of Radiotherapy Devices, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria. Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain: Shower Chairs Market  – Global Industry Analysis and Opportunity Assessment 2021 – 2031 Infrared Thermometer Market  – Global Industry Analysis and Opportunity Assessment 2021 – 2031 About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact:

Varian Medical Systems Investments

15 Investments

Varian Medical Systems has made 15 investments. Their latest investment was in COTA as part of their Convertible Note on November 11, 2020.

CBI Logo

Varian Medical Systems Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/10/2020

Convertible Note

COTA

$10M

No

6

6/8/2020

Series C - II

HistoSonics

$40M

No

6

5/6/2020

Series C

Arterys

$28M

No

2

1/1/2020

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

9/16/2019

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/10/2020

6/8/2020

5/6/2020

1/1/2020

9/16/2019

Round

Convertible Note

Series C - II

Series C

Corporate Minority

Corporate Minority

Company

COTA

HistoSonics

Arterys

Subscribe to see more

Subscribe to see more

Amount

$10M

$40M

$28M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

6

2

10

10

Varian Medical Systems Portfolio Exits

4 Portfolio Exits

Varian Medical Systems has 4 portfolio exits. Their latest portfolio exit was GRAIL on September 21, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/21/2020

Acquired

$99M

24

6/26/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/12/2018

Acquired

Subscribe to see more

Subscribe to see more

10

1/25/2013

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/21/2020

6/26/2020

12/12/2018

1/25/2013

Exit

Acquired

IPO

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

24

10

10

10

Varian Medical Systems Acquisitions

21 Acquisitions

Varian Medical Systems acquired 21 companies. Their latest acquisition was Boston Scientific - Microsphere Business on July 02, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/2/2019

$99M

Acquired Unit

1

6/12/2019

$99M

Acquired

1

6/10/2019

$99M

Acquired

1

6/10/2019

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

5/21/2019

Other Venture Capital

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/2/2019

6/12/2019

6/10/2019

6/10/2019

5/21/2019

Investment Stage

Other Venture Capital

Other Venture Capital

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acquired Unit

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Varian Medical Systems Partners & Customers

10 Partners and customers

Varian Medical Systems has 10 strategic partners and customers. Varian Medical Systems recently partnered with Icon Group on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/5/2022

Partner

Australia

Icon Group enters AI radiology research partnership with Varian

`` Timely care is critical to improving outcomes for patients , and this partnership with Icon Group builds on our efforts to reduce the time that elapses between a cancer diagnosis and treatment , '' said Varian president of Radiation Oncology Solutions Kevin O'Reilly .

1

4/29/2022

Partner

Australia

Varian Partners with Icon Group to Advance Patient-centric Solutions

The strategic partnership enables business leaders across Varian , Siemens Healthineers , and Icon Group to collaborate on new learnings and techniques in radiation therapy to advance patient-centric solutions and accelerate the development of market-ready products .

2

4/27/2021

Client

Australia

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care | Varian.

This agreement further strengthens the global partnership between Varian and Icon Group , together increasing access to care across regional and underserviced areas in Australia and Asia .

5

11/10/2020

Partner

United States

Subscribe to see more

Subscribe to see more

0

9/3/2020

Partner

Australia

Subscribe to see more

Subscribe to see more

10

Date

5/5/2022

4/29/2022

4/27/2021

11/10/2020

9/3/2020

Type

Partner

Partner

Client

Partner

Partner

Business Partner

Country

Australia

Australia

Australia

United States

Australia

News Snippet

Icon Group enters AI radiology research partnership with Varian

`` Timely care is critical to improving outcomes for patients , and this partnership with Icon Group builds on our efforts to reduce the time that elapses between a cancer diagnosis and treatment , '' said Varian president of Radiation Oncology Solutions Kevin O'Reilly .

Varian Partners with Icon Group to Advance Patient-centric Solutions

The strategic partnership enables business leaders across Varian , Siemens Healthineers , and Icon Group to collaborate on new learnings and techniques in radiation therapy to advance patient-centric solutions and accelerate the development of market-ready products .

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care | Varian.

This agreement further strengthens the global partnership between Varian and Icon Group , together increasing access to care across regional and underserviced areas in Australia and Asia .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

5

0

10

Varian Medical Systems Service Providers

1 Service Provider

Varian Medical Systems has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Corporate Majority - P2P

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Corporate Majority - P2P

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Varian Medical Systems Team

6 Team Members

Varian Medical Systems has 6 team members, including current Chief Medical Officer, Joseph R. Steele.

Name

Work History

Title

Status

Joseph R. Steele

Boston Scientific, and Covalent Radiology

Chief Medical Officer

Current

Deepak Khuntia

Senior Vice President

Current

Rafael Torres

GE Ventures, GE Equity Partners, GE Healthcare, The Boston Consulting Group, AT Investments, and Citibank

Senior Vice President

Current

Moataz Karmalawy

President

Former

Sunny Sanyal

President

Former

Name

Joseph R. Steele

Deepak Khuntia

Rafael Torres

Moataz Karmalawy

Sunny Sanyal

Work History

Boston Scientific, and Covalent Radiology

GE Ventures, GE Equity Partners, GE Healthcare, The Boston Consulting Group, AT Investments, and Citibank

Title

Chief Medical Officer

Senior Vice President

Senior Vice President

President

President

Status

Current

Current

Current

Former

Former

You May Also Like

Elekta Logo
Elekta

Elekta is a human-care company focused on clinical solutions for treating cancer and brain disorders. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Mim Software Logo
Mim Software

Mim Software is a medical device company known for developing the Mim 5.2 (brachy).

TheraPanacea Logo
TheraPanacea

TheraPanacea is a startup from the research laboratories of Inria and CentraleSupelec which has created software for radiation oncology. Using artificial intelligence technologies, the MedTech solutions allow for more effective treatment and reduction of side effects.

MVision AI Logo
MVision AI

MVision AI specializes in the field of medical imaging and artificial intelligence. By applying AI to radiotherapy imaging, MVision AI reduces treatment planning time, saves costs, and ultimately improves treatment results.

M
Manteia

Manteia focuses on radiotherapy treatment system research and development. Manteia's product lines include automatic target volume delineation software, dose calculation and evaluation system, remote cloud system, and intelligent adaptive radiotherapy system.

Navigating Cancer Logo
Navigating Cancer

Navigating Cancer develops easy to use tools for cancer survivors to help manage recovery and obtain care. The company brings together the information, patient education materials and latest research from resources including the National Cancer Institute and non-profit advocacy groups.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.